Codexis to Participate in Upcoming Healthcare Conferences

Rhea-AI Summary

Codexis, Inc. (NASDAQ: CDXS) will participate in four upcoming investor conferences. The conferences include Jefferies London Healthcare Conference, Stifel 2023 Healthcare Conference, Stephens Annual Investment Conference, and Craig-Hallum Alpha Select Conference. Management will participate in fireside chats and host investor meetings. Live webcasts and replays will be available on the company's website.

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in four upcoming investor conferences.

The Jefferies London Healthcare Conference (London, UK)  

• Tuesday, November 14, 2023, at 1:00 pm GMT, management will participate in a fireside chat
  

The Stifel 2023 Healthcare Conference (New York, NY)

• Tuesday, November 14, 2023, at 9:10 am ET, management will participate in a fireside chat
  

The Stephens Annual Investment Conference (Nashville, TN)

• Wednesday, November 15, 2023, at 9:00 am CT, management will participate in a fireside chat
  

The 14^th Annual Craig-Hallum Alpha Select Conference (New York, NY)

• Thursday, November 16, 2023, management will host 1x1 investor meetings
  

Live webcasts of each fireside chat will be available on the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay of each fireside chat will be archived for 90 days following the presentation date.

About Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

Media Contact
Lauren Musto
(781) 572-1147
media@codexis.com

FAQ

What is the company participating in?

Codexis, Inc. is participating in four upcoming investor conferences.

Which conferences will Codexis be attending?

Codexis will attend the Jefferies London Healthcare Conference, Stifel 2023 Healthcare Conference, Stephens Annual Investment Conference, and Craig-Hallum Alpha Select Conference.

What will management do during the conferences?

Management will participate in fireside chats and host investor meetings.

Where can I watch the fireside chats?

Live webcasts of the fireside chats will be available on Codexis' website.

Will there be replays of the fireside chats?

Yes, replays of the fireside chats will be archived on Codexis' website for 90 days.